WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin
The Hindu
A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said.
The World Health Organisation (WHO) said “more information” is “required” from Bharat Biotech, which is seeking emergency use listing (EUL) for its . The latest guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that “More information required”. A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said. According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential.More Related News

As Gor makes first trip as U.S. Special envoy to South Asia, Delhi watches strategic signals closely
Sergio Gor's inaugural trip as U.S. Special Envoy to South Asia signals strategic U.S. engagement amid regional tensions.

Iran strikes near Israeli nuclear research center as Trump threatens attacks on Iranian power plants
Iran's missile strikes near Israel's nuclear site escalate tensions as Trump threatens retaliation against Iranian power plants.











